Already, 2023 is shaping up to be a significant year in the employee benefits and executive compensation space, as organizations grapple with a host of new regulatory requirements, mounting cyber risks and fallout from the reversal of Roe v. Wade. Just last week, pharmacy chain Walgreens announced it would stop selling abortion pills in 20 states after being threatened with legal action by Republican officials; the state of California has since announced plans to cut ties with the company. READ MORE